Kirske David
X4 Pharmaceuticals, Inc. · Chief Financial Officer
Kirske David is listed in filings as Chief Financial Officer at X4 Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including sale activity. Recent filings connect the profile to X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Aug 14, 2025 to May 13, 2026. Reported amounts are shown as $72.8K to $1.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $73k17k shares | SellMay 12, 2026 | $4.29 | $3.82 |